SCHEMBL4383313

SCHEMBL4383313

CCc1cc(Br)cnc1-c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.42
KDM4E B2RXH2 3/20 0.42
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
LMNA P02545 2/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CCR1 P32246 1/20 0.39
CCR5 P51681 1/20 0.39
CCR8 P51685 1/20 0.39
METAP1 P53582 1/20 0.39
BLM P54132 1/20 0.39
HIF1A Q16665 1/20 0.39
DOHH Q9BU89 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
CYP2A6 P11509 1/20 0.38
PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28105957 0.84 CBFB (0.43) NPC1KDM4EPTGS1PTGS2LMNA
SCHEMBL4383311 0.82 GBA1 (0.40) NPC1KDM4ECYP1A2ALDH1A1MAPT
SCHEMBL4388570 0.81 SLC2A1 (0.37) NPC1KDM4EPTGS1PTGS2LMNA
SCHEMBL4391328 0.79 KDM4E (0.54) NPC1KDM4EPTGS1PTGS2LMNA
SCHEMBL27534321 0.78 KDM4E (0.46) NPC1KDM4EPTGS1PTGS2LMNA
SCHEMBL5089682 0.76 KDM4E (0.48) NPC1KDM4ETRPM8LMNACYP1A2
SCHEMBL30551751 0.76 KDM4E (0.48) NPC1KDM4ETRPM8LMNACYP1A2
SCHEMBL27529862 0.76 KDM4E (0.43) NPC1KDM4ELMNACYP1A2POLB
Iodide SCHEMBL8962203 0.75 KDM4E (0.46) NPC1KDM4ETRPM8LMNACYP1A2
SCHEMBL19053833 0.74 CYP2A6 (0.43) NPC1KDM4EPTGS1PTGS2TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084608-B2 2,2′ -bipyridine derivative having a reactive silyl group, its production method, and transition metal complex SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-12-27 US disclosed
US-20090299068-A1 2,2' -BIPYRIDINE DERIVATIVE HAVING A REACTIVE SILYL GROUP, ITS PRODUCTION METHOD, AND TRANSITION METAL COMPLEX SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
EP-2128165-A1 2, 2´-bipyridine derivatives having reactive silyl group, production methods, transition metal complexes thereof Shin-Etsu Chemical Co., Ltd. (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090299068-A1 2,2' -BIPYRIDINE DERIVATIVE HAVING A REACTIVE SILYL GROUP, ITS PRODUCTION METHOD, AND TRANSITION METAL COMPLEX CBR3, TST, HRH3 NPC1 1938/4885KDM4E 3085/4885PTGS1 2469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.